We are live on ! Find out more
INCY icon

Incyte

494 hedge funds and large institutions have $14B invested in Incyte in 2021 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 205 increasing their positions, 155 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 155

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

2% more capital inflows, than outflows

Capital inflows: $1.32B | Capital outflows: $1.29B

0.86% less ownership

Funds ownership: 93% → 92.14% (-0.86%)

6% less call options, than puts

Call options by funds: $106M | Put options by funds: $112M

6% less funds holding

Funds holding: 523 → 494 (-29)

29% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 72

Holders
494
Holders Change
-29
Holders Change %
-5.54%
% of All Funds
8.62%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
51
Increased
205
Reduced
155
Closed
72
Calls
$106M
Puts
$112M
Net Calls
-$6.26M
Net Calls Change
-$24.7M

INCY Hedge Fund Activity: Q3 2021 in Review

494 of the 5,730 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q3 2021, worth a combined $14B — down 19% from $17.2B a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of INCY and 51 opened new positions — a net loss of 21 holders — while 155 trimmed existing stakes and 205 added.

The largest buyer was Dodge & Cox, adding an estimated $219M. The largest seller was T. Rowe Price Associates, cutting an estimated $734M.

  • 494 institutional investors held Incyte (INCY) as of Q3 2021, down from 523 in Q2 2021.
  • Funds reported $14B of Incyte stock for Q3 2021, down 19% quarter-over-quarter.
  • 51 funds opened new Incyte positions in Q3 2021 and 72 closed out, a net change of -21 holders.
  • The largest Incyte buyer in Q3 2021 was Dodge & Cox, an estimated $219M added.
  • The largest Incyte seller in Q3 2021 was T. Rowe Price Associates, an estimated $734M sold.

Based on aggregated 13F filings for Q3 2021.